$RGBP 0.0495 +0.0019 (+4.03%) The company is rapidly expanding the number of activating compounds in its portfolio. The NR2F6 nuclear receptor has been identified as a potentially very important immune cell inhibitor & cancer stem cell differentiator. http://prn.to/2n9ZnGG #RT
ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.